Smith, Moore & Co’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $785K | Sell |
10,929
-324
| -3% | -$25K | 0.06% | 251 |
|
|
2025
Q4 | $893K | Sell |
11,253
-168
| -1% | -$13.2K | 0.07% | 217 |
|
|
2025
Q3 | $861K | Buy |
11,421
+195
| +2% | +$13.4K | 0.07% | 233 |
|
|
2025
Q2 | $774K | Sell |
11,226
-622
| -5% | -$40.8K | 0.07% | 242 |
|
|
2025
Q1 | $803K | Sell |
11,848
-498
| -4% | -$29.8K | 0.07% | 234 |
|
|
2024
Q4 | $554K | Sell |
12,346
-4,219
| -25% | -$237K | 0.05% | 274 |
|
|
2024
Q3 | $1.04M | Sell |
16,565
-3,583
| -18% | -$209K | 0.1% | 176 |
|
|
2024
Q2 | $1.19M | Buy |
20,148
+53
| +0.3% | +$3.31K | 0.12% | 153 |
|
|
2024
Q1 | $1.6M | Sell |
20,095
-9,414
| -32% | -$719K | 0.17% | 121 |
|
|
2023
Q4 | $2.33M | Sell |
29,509
-5,222
| -15% | -$372K | 0.27% | 76 |
|
|
2023
Q3 | $2.42M | Sell |
34,731
-1,576
| -4% | -$112K | 0.32% | 68 |
|
|
2023
Q2 | $2.51M | Buy |
36,307
+3,256
| +10% | +$232K | 0.32% | 66 |
|
|
2023
Q1 | $2.46M | Buy |
33,051
+1,256
| +4% | +$105K | 0.33% | 64 |
|
|
2022
Q4 | $2.96M | Buy |
31,795
+13
| +0% | +$1.25K | 0.41% | 45 |
|
|
2022
Q3 | $3.03M | Sell |
31,782
-1,109
| -3% | -$110K | 0.46% | 44 |
|
|
2022
Q2 | $3.05M | Sell |
32,891
-661
| -2% | -$64.5K | 0.47% | 42 |
|
|
2022
Q1 | $3.4M | Buy |
33,552
+1,203
| +4% | +$126K | 0.46% | 43 |
|
|
2021
Q4 | $3.34M | Buy |
32,349
+188
| +0.6% | +$17.4K | 0.46% | 42 |
|
|
2021
Q3 | $2.73M | Buy |
32,161
+306
| +1% | +$25.6K | 0.42% | 50 |
|
|
2021
Q2 | $2.66M | Buy |
31,855
+490
| +2% | +$40.1K | 0.4% | 51 |
|
|
2021
Q1 | $2.36M | Sell |
31,365
-1,199
| -4% | -$87.3K | 0.38% | 54 |
|
|
2020
Q4 | $2.22M | Buy |
32,564
+10,622
| +48% | +$691K | 0.42% | 51 |
|
|
2020
Q3 | $1.28M | Buy |
21,942
+1,973
| +10% | +$123K | 0.27% | 72 |
|
|
2020
Q2 | $1.3M | Buy |
19,969
+214
| +1% | +$13.5K | 0.29% | 69 |
|
|
2020
Q1 | $1.17M | Buy |
19,755
+670
| +4% | +$44.7K | 0.31% | 66 |
|
|
2019
Q4 | $1.42M | Sell |
19,085
-1,551
| -8% | -$109K | 0.29% | 67 |
|
|
2019
Q3 | $1.3M | Buy |
20,636
+7,168
| +53% | +$425K | 0.29% | 66 |
|
|
2019
Q2 | $734K | Buy |
13,468
+3,494
| +35% | +$188K | 0.17% | 125 |
|
|
2019
Q1 | $538K | Buy |
9,974
+194
| +2% | +$12K | 0.13% | 160 |
|
|
2018
Q4 | $641K | Buy |
9,780
+647
| +7% | +$48.3K | 0.17% | 126 |
|
|
2018
Q3 | $719K | Sell |
9,133
-1,436
| -14% | -$103K | 0.16% | 126 |
|
|
2018
Q2 | $680K | Buy |
10,569
+2,615
| +33% | +$172K | 0.17% | 127 |
|
|
2018
Q1 | $495K | Buy |
7,954
+871
| +12% | +$62.5K | 0.13% | 154 |
|
|
2017
Q4 | $514K | Buy |
7,083
+1,157
| +20% | +$84.1K | 0.14% | 146 |
|
|
2017
Q3 | $482K | Buy |
+5,926
| New | +$469K | 0.14% | 147 |
|
Other funds holding CVS
VCM
VPM
Smith, Moore & Co's CVS Position: Q1 2026 in Review
Smith, Moore & Co reduced its CVS Health (CVS) stake by 2.9% in Q1 2026, selling an estimated $25K and leaving 10,929 shares worth $785K. The position accounts for 0.06% of the portfolio, ranked #251.
Smith, Moore & Co first reported a position in CVS in Q3 2017 and has held it in 35 quarters since. The position peaked at $3.4M in Q1 2022. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Smith, Moore & Co held 10,929 shares of CVS Health worth $785K as of Q1 2026.
- Smith, Moore & Co sold 324 CVS Health shares in Q1 2026, an estimated $25K.
- CVS Health made up 0.06% of Smith, Moore & Co's portfolio in Q1 2026, its #251 holding.
- Smith, Moore & Co first reported a position in CVS Health in Q3 2017 and has held it in 35 quarters since.
- Smith, Moore & Co's CVS Health position peaked at $3.4M in Q1 2022.
- 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Smith, Moore & Co's 13F filing for Q1 2026, filed 5 May 2026.